Innovita Biological Technology Co Ltd Class A 688253
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 36.19
- Day Range
- CNY 35.30–36.93
- 52-Week Range
- CNY 19.12–41.01
- Bid/Ask
- CNY 36.33 / CNY 36.36
- Market Cap
- CNY 4.94 Bil
- Volume/Avg
- 3.0 Mil / 3.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 20.80
- Price/Sales
- 7.93
- Dividend Yield (Trailing)
- 0.46%
- Dividend Yield (Forward)
- 0.46%
- Total Yield
- 0.46%
Company Profile
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production and sales of POCT in vitro diagnostic products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 439
- Website
- https://www.innovita.com.cn
Comparables
Valuation
|
Metric
|
688253
|
000710
|
688217
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.80 | — | 71.89 |
Price/Book Value | 2.48 | 1.64 | 1.55 |
Price/Sales | 7.93 | 2.79 | 5.24 |
Price/Cash Flow | 12.01 | 29.28 | 69.58 |
Price/Earnings
688253
000710
688217
Financial Strength
|
Metric
|
688253
|
000710
|
688217
|
|---|---|---|---|
Quick Ratio | 10.60 | 1.63 | 9.93 |
Current Ratio | 11.04 | 2.02 | 11.97 |
Interest Coverage | 1,693.02 | — | −14.95 |
Quick Ratio
688253
000710
688217
Profitability
|
Metric
|
688253
|
000710
|
688217
|
|---|---|---|---|
Return on Assets (Normalized) | 4.47% | −2.24% | 0.35% |
Return on Equity (Normalized) | 4.81% | −3.20% | 0.39% |
Return on Invested Capital (Normalized) | 4.51% | −2.73% | 0.15% |
Return on Assets
688253
000710
688217
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Djfhkznvc | Flcyz | $570.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Cbbxkrkjv | Vdmfgc | $103.9 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Ftlhcdnly | Phkwcsv | $99.6 Bil | |
MRNA
| Moderna Inc | Sbcytjdp | Lyw | $42.7 Bil | |
ARGX
| argenx SE ADR | Ghlsdhrm | Pxw | $22.2 Bil | |
BNTX
| BioNTech SE ADR | Hjzyymfs | Kmz | $21.7 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Lzvxvbp | Mtwwjh | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Xqwdkzkt | Plpqyt | $15.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Xxtjwtjhrb | Rnjmd | $12.7 Bil | |
INCY
| Incyte Corp | Snqkdkbbx | Sthwt | $11.9 Bil |